<?xml version='1.0' encoding='utf-8'?>
<document id="30010032"><sentence text="Interaction between 3,4‑dichlorophenyl‑propenoyl‑sec.‑butylamine (3,4‑DCPB), an antiepileptic drug, and cytochrome P450 in rat liver microsomes and recombinant human enzymes in vitro."><entity charOffset="20-64" id="DDI-PubMed.30010032.s1.e0" text="3,4‑dichlorophenyl‑propenoyl‑sec.‑butylamine" /></sentence><sentence text="The compound 3,4‑dichlorophenyl‑propenoyl‑sec"><entity charOffset="13-45" id="DDI-PubMed.30010032.s2.e0" text="3,4‑dichlorophenyl‑propenoyl‑sec" /></sentence><sentence text="‑butylamine (3,4‑DCPB) is an antiepileptic drug"><entity charOffset="0-11" id="DDI-PubMed.30010032.s3.e0" text="‑butylamine" /></sentence><sentence text=" The purpose of the present research was to identify cytochrome P450 (CYP450) responsible for the metabolism of 3,4‑DCPB and evaluate the effects of 3,4‑DCPB on the activities of CYP450 enzymes" /><sentence text=" 3,4‑DCPB was incubated with rat liver microsomes (RLMs) plus six CYP450 enzyme-specific inhibitors, or six recombinant human CYP450 enzymes (rhCYP450s)" /><sentence text=" The concentrations of 3,4‑DCPB and six CYP450 enzyme-activities probe drugs were detected by high-performance liquid chromatographic (HPLC)" /><sentence text=" The results showed that the prototype of 3,4‑DCPB was metabolized by multiple CYP450 enzymes into three metabolites, and the predominant isoforms were CYP2D6 (metabolite M1), CYP1A2 (M2), CYP2C19 and CYP3A4 (M3), respectively" /><sentence text=", in the presence of β-NADPH (1 mM) in RLMs or rhCYP450s"><entity charOffset="21-28" id="DDI-PubMed.30010032.s8.e0" text="β-NADPH" /></sentence><sentence text=" Compared with the control (PB-), phenobarbital pre-treatment (PB+) significantly enhanced levels (all of p &lt; 0" /><sentence text="01) of hydroxylmethytobutamide (CYP2C9), 4‑hydroxy‑mephenytoin (CYP2C19), acetaminophen (CYP1A2), 6‑hydroxychlorzoxazone (CYP2E1) and oxidized nifedipine (CYP3A4), respectively, in spite of dextrophan (CYP2D6) was not markedly enhanced in RLMs"><entity charOffset="7-30" id="DDI-PubMed.30010032.s10.e0" text="hydroxylmethytobutamide" /><entity charOffset="32-38" id="DDI-PubMed.30010032.s10.e1" text="CYP2C9" /><entity charOffset="41-62" id="DDI-PubMed.30010032.s10.e2" text="4‑hydroxy‑mephenytoin" /><entity charOffset="64-71" id="DDI-PubMed.30010032.s10.e3" text="CYP2C19" /><entity charOffset="74-87" id="DDI-PubMed.30010032.s10.e4" text="acetaminophen" /><entity charOffset="89-95" id="DDI-PubMed.30010032.s10.e5" text="CYP1A2" /><entity charOffset="98-120" id="DDI-PubMed.30010032.s10.e6" text="6‑hydroxychlorzoxazone" /><entity charOffset="122-128" id="DDI-PubMed.30010032.s10.e7" text="CYP2E1" /><entity charOffset="143-153" id="DDI-PubMed.30010032.s10.e8" text="nifedipine" /><entity charOffset="190-200" id="DDI-PubMed.30010032.s10.e9" text="dextrophan" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e0" e2="DDI-PubMed.30010032.s10.e0" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e0" e2="DDI-PubMed.30010032.s10.e1" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e0" e2="DDI-PubMed.30010032.s10.e2" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e0" e2="DDI-PubMed.30010032.s10.e3" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e0" e2="DDI-PubMed.30010032.s10.e4" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e0" e2="DDI-PubMed.30010032.s10.e5" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e0" e2="DDI-PubMed.30010032.s10.e6" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e0" e2="DDI-PubMed.30010032.s10.e7" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e0" e2="DDI-PubMed.30010032.s10.e8" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e0" e2="DDI-PubMed.30010032.s10.e9" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e1" e2="DDI-PubMed.30010032.s10.e1" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e1" e2="DDI-PubMed.30010032.s10.e2" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e1" e2="DDI-PubMed.30010032.s10.e3" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e1" e2="DDI-PubMed.30010032.s10.e4" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e1" e2="DDI-PubMed.30010032.s10.e5" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e1" e2="DDI-PubMed.30010032.s10.e6" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e1" e2="DDI-PubMed.30010032.s10.e7" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e1" e2="DDI-PubMed.30010032.s10.e8" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e1" e2="DDI-PubMed.30010032.s10.e9" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e2" e2="DDI-PubMed.30010032.s10.e2" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e2" e2="DDI-PubMed.30010032.s10.e3" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e2" e2="DDI-PubMed.30010032.s10.e4" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e2" e2="DDI-PubMed.30010032.s10.e5" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e2" e2="DDI-PubMed.30010032.s10.e6" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e2" e2="DDI-PubMed.30010032.s10.e7" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e2" e2="DDI-PubMed.30010032.s10.e8" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e2" e2="DDI-PubMed.30010032.s10.e9" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e3" e2="DDI-PubMed.30010032.s10.e3" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e3" e2="DDI-PubMed.30010032.s10.e4" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e3" e2="DDI-PubMed.30010032.s10.e5" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e3" e2="DDI-PubMed.30010032.s10.e6" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e3" e2="DDI-PubMed.30010032.s10.e7" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e3" e2="DDI-PubMed.30010032.s10.e8" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e3" e2="DDI-PubMed.30010032.s10.e9" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e4" e2="DDI-PubMed.30010032.s10.e4" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e4" e2="DDI-PubMed.30010032.s10.e5" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e4" e2="DDI-PubMed.30010032.s10.e6" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e4" e2="DDI-PubMed.30010032.s10.e7" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e4" e2="DDI-PubMed.30010032.s10.e8" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e4" e2="DDI-PubMed.30010032.s10.e9" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e5" e2="DDI-PubMed.30010032.s10.e5" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e5" e2="DDI-PubMed.30010032.s10.e6" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e5" e2="DDI-PubMed.30010032.s10.e7" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e5" e2="DDI-PubMed.30010032.s10.e8" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e5" e2="DDI-PubMed.30010032.s10.e9" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e6" e2="DDI-PubMed.30010032.s10.e6" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e6" e2="DDI-PubMed.30010032.s10.e7" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e6" e2="DDI-PubMed.30010032.s10.e8" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e6" e2="DDI-PubMed.30010032.s10.e9" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e7" e2="DDI-PubMed.30010032.s10.e7" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e7" e2="DDI-PubMed.30010032.s10.e8" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e7" e2="DDI-PubMed.30010032.s10.e9" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e8" e2="DDI-PubMed.30010032.s10.e8" /><pair ddi="false" e1="DDI-PubMed.30010032.s10.e8" e2="DDI-PubMed.30010032.s10.e9" /></sentence><sentence text=" Conversely, the inhibitory ratios of 3,4‑DCPB (16 μg/mL, 59 μM) on the activities of CYP2C9, CYP2C19, CYP1A2 and CYP2D6 were 97" /><sentence text="6%, 59" /><sentence text="0%, 53" /><sentence text="5% and 36" /><sentence text="5%, respectively" /><sentence text=" However, CYP2E1 (both of PB- and PB+) and CYP3A4 (PB+) were not inhibited by 3,4‑DCPB in RLMs" /><sentence text=" In conclusion, the present study showed that 3,4‑DCPB was metabolized by multiple CYP450 enzymes" /><sentence text=" 3,4‑DCPB inhibited the activities of CYP2C9, CYP2C19, CYP1A2 and CYP2D6, rather than that CYP2E1 and CYP3A4 enzymes, suggesting that the different effects of 3,4‑DCPB on the CYP450 enzymes might influence metabolic drug-drug interaction in antiepileptics therapy" /><sentence text="" /></document>